|
|
| (5 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| − | {{group
| + | #REDIRECT[[Roche]] |
| − | |wikipedia=https://en.wikipedia.org/wiki/Hoffmann-La_Roche
| |
| − | |constitutes=Big pharma
| |
| − | |leaders=
| |
| − | |logo=Roche.svg
| |
| − | |twitter=
| |
| − | |start=1896
| |
| − | |founders=Fritz Hoffmann-La Roche
| |
| − | |headquarters=
| |
| − | }}
| |
| − | | |
| − | =
| |
| − | | |
| − | ==2009 Tamiflu sales==
| |
| − | Roche profited from the [[2009 swine flu panic]]. At the time [[Donald Rumsfeld]] sat on its board of directors and held 4bn worth of stocks. Tamiflu was not selling well before the "pandemic" and Roche's profits were dwindling due to outrunning patents. Rumsfeld (then Minister of Defense) denied any conflict of interest. <ref name=Profiteure_der_Angst>
| |
| − | Profiteure der Angst (Profits from Fear) (Fr/Ger), [[ARTE]] documentary, Youtube ID: 0mlim_sQsRI
| |
| − | </ref>(00:34:47)
| |
| − | | |
| − | ==nCoV-2019 antibody test==
| |
| − | Mai, 2020: The test is the third granted ''emergency approval by the [[FDA]]'' in a urgent procedure and the first commercially available. It gives quick results (18 Min.) and will be accepted worldwide in what has been touted one of Roche's biggest deals. <ref>
| |
| − | https://www.marketwatch.com/story/roche-coronavirus-test-gets-emergency-fda-approval-2020-03-13
| |
| − | </ref>
| |
| − | The test is not based on the PCR method (which directly detects parts of viral RNA) but addresses antibodies built by the immune system after 1-2 weeks of contact. These may not be specific with a risk for false positives stemming from common cold viruses. The test is self-approved by Roche with the FDA merely giving green light. <ref>
| |
| − | https://www.deutsche-apotheker-zeitung.de/news/artikel/2020/04/14/antikoerpertests-auf-corona-risiko-von-fehlinterpretation
| |
| − | </ref>
| |
| − | | |
| − | {{SMWDocs}}
| |
| − | ==References==
| |
| − | {{reflist}}
| |
| − | {{Stub}}
| |
